The Outcome after Laser Therapy of Monochorionic Twin Pregnancies Complicated by Twin-Twin Transfusion Syndrome with Coexistent Selective Fetal Growth Restriction

Javier U. Ortiz,Johanna Guggenberger,Oliver Graupner,Eva Ostermayer,Bettina Kuschel,Silvia M. Lobmaier
DOI: https://doi.org/10.3390/jcm13082432
IF: 3.9
2024-04-22
Journal of Clinical Medicine
Abstract:Most previous studies evaluated outcomes of twin–twin transfusion syndrome (TTTS) without considering the coexistence of selective fetal growth restriction (sFGR). The objectives of this study were to compare twin survival and pregnancy complications after laser therapy of TTTS with and without sFGR. Methods: For this purpose, a retrospective cohort study including 98 monochorionic diamniotic twins and three dichorionic triamniotic triplets treated in a single tertiary center was conducted. Results: Overall, 46 twins had selective fetal growth restriction (26 type I, 13 type II, 7 type III). At birth, donor survival (61% vs. 91%), double survival (57% vs. 82%), and overall survival (75% vs. 88%) were significantly lower in the group with coexistent sFGR. Recipient survival (89% vs. 86%), miscarriage (7% vs. 2%), PPROM < 32 weeks (48% vs. 29%), and preterm delivery < 32 weeks (52% vs. 45%) were not significantly higher in the group with coexistent sFGR. Donor twins with sFGR type I (69% vs. 91%) and types II–III (50% vs. 91%) showed significantly lower survival than those without sFGR. Multivariate regression analysis identified sFGR and its subtypes as independent predictors of donor demise. Conclusions: the coexistence of sFGR in TTTS pregnancies was associated with poor donor outcomes and is probably the most important predictor of donor survival.
medicine, general & internal
What problem does this paper attempt to address?
This paper mainly discusses a complication that occurs in monochorionic diamniotic twin pregnancies, namely twin-to-twin transfusion syndrome (TTTS) coexisting with selective fetal growth restriction (sFGR), and the outcomes after laser therapy. The aim of the study is to compare the survival rate and pregnancy complications of TTTS twins with and without sFGR after receiving laser treatment. Among 98 pairs of monochorionic diamniotic twins and 3 sets of trichorionic triamniotic triplets, sFGR was present in 46 pairs (46%). The study found that compared to twins without sFGR, twins with sFGR had significantly lower donor (supply) twin survival rate, overall twin survival rate, and overall survival rate at birth. Although laser therapy can improve the prognosis of TTTS, the existence of sFGR has a particularly negative impact on the survival of the donor twin, which may be the most important factor in predicting donor twin survival. The paper also analyzed pregnancy complications such as miscarriage, preterm birth, and oligohydramnios, and identified sFGR and its subtypes as independent predictors of donor twin death through multivariate logistic regression analysis. The study emphasized the importance of sFGR in TTTS and recommended informing patients about the impact of sFGR on the survival of the donor twin during preoperative consultation. In conclusion, this paper reveals the negative impact of sFGR on the survival rate of twin pregnancies after laser therapy in TTTS, especially for the donor twin, and presents prognostic factors that clinical doctors need to consider.